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Obesity and dietary fats are well known risk factors for the pathogenesis of
neurodegenerative diseases. The analysis of specific markers, whose brain level
can be affected by diet, might contribute to unveil the intersection between
inflammation/obesity and neurodegeneration. Haptoglobin (Hpt) is an acute phase
protein, which acts as antioxidant by binding free haemoglobin (Hb), thus neutralizing
its pro-oxidative action. We previously demonstrated that Hpt plays critical functions in
brain, modulating cholesterol trafficking in neuroblastoma cell lines, beta-amyloid (Aβ)
uptake by astrocyte, and limiting Aβ toxicity on these cells. A major aim of this study
was to evaluate whether a long term (12 or 24 weeks) high-fat diet (HFD) influences
Hpt and Hb expression in rat hippocampus. We also assessed the development of
obesity-induced inflammation by measuring hippocampal level of TNF-alpha, and the
extent of protein oxidation by titrating nitro-tyrosine (N-Tyr). Hpt concentration was lower
(p < 0.001) in hippocampus of HFD rats than in control animals, both in the 12 and in
the 24 weeks fed groups. HFD was also associated in hippocampus with the increase
of Hb level (p < 0.01), inflammation and protein oxidative modification, as evidenced
by the increase in the concentration of TNF-alpha and nitro-tyrosine. In fact, TNF-
alpha concentration was higher in rats receiving HFD for 12 (p < 0.01) or 24 weeks
(p < 0.001) compared to those receiving the control diet. N-Tyr concentration was
more elevated in hippocampus of HFD than in control rats in both 12 weeks (p = 0.04)
and 24 weeks groups (p = 0.01), and a positive correlation between Hb and N-Tyr
concentration was found in each group. Finally, we found that the treatment of the
human glioblastoma-astrocytoma cell line U-87 MG with cholesterol and fatty acids,
such as palmitic and linoleic acid, significantly impairs (p < 0.001) Hpt secretion in the
extracellular compartment. We hypothesize that the HFD-dependent decrease of Hpt
in hippocampus, as associated with Hb increase, might enhance the oxidative stress
induced by free Hb. Altogether our data, identifying Hpt as a molecule modulated in the
brain by dietary fats, may represent one of the first steps in the comprehension of the
molecular mechanisms underlying the diet-related effects in the nervous system.
Keywords: haptoglobin, hemoglobin, TNF-alpha, nitro-tyrosine, high-fat diet, human astrocytoma cell line U-87
MG, rat, hippocampus
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INTRODUCTION
Obesity relationship with various health problems has been well
described in several recent studies (Haslam and James, 2005;
Malnick and Knobler, 2006). In the last decade, obesity, and
dietary fats were identiﬁed as risk factors for cognitive decline and
various types of neurodegenerative dementias (Kalmijn, 2000;
Solfrizzi et al., 2003; Gustafson, 2008; Craft, 2009; Sellbom and
Gunstad, 2012). Indeed, human epidemiological studies revealed
a correlation between a high-fat diet (HFD) and cognitive
impairment (Elias et al., 2003; Morris et al., 2004; Zhang et al.,
2006), as well as between body mass index and Alzheimer’s
Disease (AD) development (Benito-León et al., 2013; Reinert
et al., 2013). In particular, it was demonstrated that a diet
enriched with saturated and trans fatty acids is associated with
increased risk for AD (Kalmijn et al., 1997; Luchsinger et al.,
2002; Morris et al., 2003). Biological mechanisms underlying
damaging eﬀects of obesity on brain are still poorly understood,
although studies on experimental models and humans have
shown that obesity is associated with increased brain oxidative
stress (Mattson et al., 2003; Zhang et al., 2005; Souza et al.,
2007) and neuroinﬂammation (Thirumangalakudi et al., 2008;
Pistell et al., 2010; Freeman et al., 2014), both implicated in
the pathogenesis of neurodegenerative diseases (Freeman et al.,
2014). Therefore, the identiﬁcation of molecules that can be
modulated by dietary fats, might contribute to clarify the speciﬁc
obesity-related eﬀects on brain physiology and pathology.
In this frame, we demonstrated that Haptoglobin (Hpt), an
acute-phase protein of inﬂammation, binds Apolipoprotein E
(ApoE), inﬂuencing ApoE-mediated cholesterol traﬃcking in
blood (Cigliano et al., 2009) and in neuroblastoma cell lines
(Spagnuolo et al., 2014a). Further, we have recently reported
that Hpt also aﬀects ApoE-dependent 24(S)-hydroxycholesterol
esteriﬁcation (La Marca et al., 2014), a key step for cholesterol
removal from the brain.
Hpt is synthesized primarily by hepatocytes, and in white
adipose tissue (WAT; Friedrichs et al., 1995; Quaye, 2008), and
its blood levels vary according to the volume of adiposity in
the body (Chiellini et al., 2004). Hpt is so far known for its
ability to bind free Haemoglobin (Hb), to transport it to the
liver and therefore to limit the pro-oxidative action of free Hb
(Quaye, 2008). Also, we previously demonstrated that Hpt acts
as antioxidant, by preventing Apolipoprotein A-I (ApoA-I) and
ApoE oxidation by free radical species (Salvatore et al., 2007,
2009). Although the presence of Hpt in the brain was ﬁrstly
suggested as a marker of blood-brain barrier (BBB) dysfunction
(Chamoun et al., 2001), diﬀerent studies demonstrated that Hpt
is produced in this compartment, in response to stress stimuli
(Lee et al., 2002; Borsody et al., 2006; Zhao et al., 2009), as
well as by human astrocytes in vitro (Maresca et al., 2015).
Further, increased Hpt concentration was found in cerebrospinal
ﬂuid (CSF) from AD patients (Johnson et al., 1992; Yerbury
and Wilson, 2010), and increased oxidation of this protein was
described in plasma of AD patients (Cocciolo et al., 2012). In
addition, we recently demonstrated that Hpt increases with the
age in rat hippocampus as well as in human CSF (Spagnuolo et al.,
2014a).
Beyond its Hb-binding function, Hpt also acts as extracellular
chaperone, by inhibiting amyloid beta (Aβ) ﬁbril formation
in vitro (Wilson et al., 2008; Yerbury et al., 2009), colocalizes with
amyloid plaques in AD (Powers et al., 1981; Veerhuis et al., 2003;
Yerbury et al., 2005), and was proposed as potential biomarker
of AD (Thambisetty, 2010). In addition, we recently provided
evidence that Hpt, due to its ability to bind both ApoE and Aβ,
promotes the formation of the ApoE/Aβ complex (Spagnuolo
et al., 2014b), which is crucial to prevent or limit Aβ neurotoxicity
and to promote its clearance. Hpt modulation of Aβ uptake by
astrocyte and its activity of limiting Aβ toxicity in these cells was
also reported (Maresca et al., 2015).
As dietary composition can negatively aﬀect hippocampal
function (Hsu and Kanoski, 2014), and Hpt modulates ApoE-
dependent cholesterol homeostasis in the brain (Spagnuolo et al.,
2014a), a major aim of this study was to evaluate whether a long
term high fat diet inﬂuences Hpt expression in rat hippocampus.
This brain region, crucial for learning and memory, is considered
one of the most vulnerable sites in early AD and other
neurodegenerative diseases development (Gómez-Isla et al., 1996;
Price et al., 2001), and is particularly susceptible to disruption by
dietary factors. In addition, in view of the previously described
Hpt antioxidant function (Salvatore et al., 2007, 2009; Quaye,
2008), we also investigated whether diet-dependent Hpt changes
are associated with inﬂammation and with changes in the level of
nitro-tyrosine (N-Tyr), here selected as marker of the extent of
protein oxidative modiﬁcation.
MATERIALS AND METHODS
Materials
Bovine serum albumin fraction V (BSA), human Hb,
phosphatidylcholine (PC) from egg yolk, 2-linoleoyl-1-
palmitoyl-sn-glycero-3-phosphocholine (LP), rabbit anti-human
Hpt IgG, mouse anti-β actin IgG, goat anti-rabbit Horseradish
Peroxidase-conjugated IgG (GAR-HRP), goat anti-mouse
Horseradish Peroxidase-conjugated IgG (GAM-HRP), rabbit
anti-human Hb, mouse anti-human Hpt, and MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], were
purchased from Sigma–Aldrich (St. Louis, MO, USA). Rabbit
anti-N-Tyr of Covalab was purchased by Vincibiochem (Vinci,
Italy). Rabbit anti-rat Hpt was from ICL Lab (distributed by
Prodotti Gianni, Milano, Italy). The dye reagent for protein
titration, enhanced chemiluminescence (ECL) reagents, and
the polyvinylidene diﬂuoride (PVDF) membrane were from
Bio-Rad (Bio-Rad, Hercules, CA, USA). Polystyrene 96-wells
ELISAMaxiSorp plates, with high aﬃnity to proteins with mixed
hydrophilic/hydrophobic domains, were purchased from Nunc
(Roskilde, Denmark). Kodak Biomax light ﬁlm, Sephacryl S-200,
CNBr-activated Sepharose 4 Fast Flow and Blue Sepharose 6 Fast
Flow resins were from GE-Healthcare Life Sciences (Milano,
Italy). DMEM, fetal bovine serum (FBS), L-glutamine, penicillin
and streptomycin were from Gibco (Life Technologies Italy,
Monza, Italy). Cell culture ﬂasks (25 and 75 cm2), 6 and 96-well
cell culture plates, and sterile pipettes of Beckton-Dickinson
(Milan, Italy) were used.
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Animal and Experimental Design
Two months old male Wistar rats (Charles River, Calco, Como,
Italy), with similar body weight (340 ± 10 g), were individually
caged in a temperature-controlled room (23 ± 1◦C) with a 12-h
light/12-h dark cycle. Animals were housed in the Animal Care
Facility at the Department of Biology, with water ad libitum,
and they were randomly divided into four experimental groups.
Two groups (control) received a standard diet (control diet, CD;
10.6% fat J/J; Mucedola 4RF21; Settimo Milanese, Milan, Italy)
for 12 (N = 8; CD 12) or 24 (N = 7; CD 24) weeks. The other
two groups (high-fat) received a HFD rich in lard (40% fat J/J)
for 12 (N = 6; HFD 12) or 24 (N = 7; HFD 24) weeks. The
composition of all dietary regimens is reported inTable 1. During
the treatments, the body weight and food intake were monitored
daily to calculate weight gain and gross energy intake. Spilled food
were collected daily for precise food intake calculation.
At the end of the experimental period, animals of each group
were anesthetized by chloral hydrate (40 mg/100 g body wt)
and killed by decapitation. Blood was collected and serum was
obtained by centrifuging at 1000 × g for 10 min before storing at
−80◦C until the biochemical measurements.
The brains were quickly removed and hippocampus was
dissected on ice. Samples were snap frozen in liquid nitrogen
immediately and stored at −80◦C for subsequent RNA and
protein isolation.
The evaluation of fat and protein content in animal carcasses
was conducted according to a published protocol (Iossa et al.,
2002).
This study was carried out in strict accordance with the
Institutional Guidelines and complied with the Italian D.L.
no.116 of January 27, 1992 of Ministero della Salute and
associated guidelines in the European Communities Council
Directive of November 24, 1986 (86/609/ECC). All animal
procedures reported herein were approved by the Institutional
Animal Care and Use Committee (CSV) of University of Naples
Federico II. All eﬀorts were made to minimize animal suﬀering
and to reduce the number of animals used.
TABLE 1 | Diet composition.
Control diet High lard diet
(g/100g diet)
Standard feed 100 51.3
Caseina g − 9.25
Lard g − 21.8
Sunflower oil g − 1.24
AIN 76 mineral mixb g − 1.46
AIN 76 Vitamin mixc g − 0.42
Choline bitartrato − 0.08
Methionine g − 0.12
Energy density kJ/g diet 15.88 20.00
Protein % 29 29
Lipid % 10.6 40
Carbohydrate % 60.4 31
aPurified high-nitrogen casein containing 88% protein, bAmerican Institute of
Nutrition (1977), cAmerican Institute of Nutrition (1980).
Cell Culture
The human glioblastoma-astrocytoma cell line U-87 MG was
kindly provided by the Institute of Genetics and Biophysics
(CNR, Naples, Italy). Cells (500,000) were seeded in 50 ml
tissue culture ﬂasks (25 cm2 surface), and grown in DMEM
supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml
penicillin, and 100 μg/ml streptomycin (complete medium) at
37◦C under humidiﬁed atmosphere of 5% CO2 in air. The
medium was changed twice a week, and cells were sub-cultivated
when conﬂuent.
U-87 MG cells were seeded into 6-well plates (at 400,000
cells/well density) in complete medium, and incubated (37◦C, 5%
CO2) for 20 h. After removal of the medium, and washing with
DMEM, the cells were used in the assays described below.
Titration of Serum Hpt
Haptoglobin concentration in individual samples was measured
by ELISA. Samples were diluted (1:1000, 1:3000, 1:9000, 1:20000,
and 1:40000) with coating buﬀer (7 mM Na2CO3, 17 mM
NaHCO3, 1.5 mMNaN3, pH 9.6), and aliquots (50 μl) were then
incubated in the wells of a microtiter plate (Immuno MaxiSorp;
overnight, 4◦C). After four washes by T-TBS (130 mM NaCl,
20 mM Tris-HCl, 0.05% Tween 20, pH 7.4) and four washes
by high salt TBS (500 mM NaCl in 20 mM Tris-HCl at pH
7.4), the wells were blocked with TBS containing 0.5% BSA
(1 h, 37◦C). After washing, the wells were incubated (1 h, 37◦C)
with 60 μl of rabbit anti-rat IgG (1: 500 dilution in T-TBS
containing 0.25% BSA) followed by 60 μl of GAR-HRP IgG
(1:3000 dilution). Peroxidase-catalyzed color development from
o-phenylenediamine was measured at 492 nm. The calibration
curve was obtained by assaying the immunoreactivity of 2, 1, 0.5,
0.25, 0.1, 0.05, 0.03 ng of puriﬁed Hpt 1-1.
Analysis of TNF-Alpha Concentration in
Hippocampus
For quantiﬁcation of TNF-alpha, proteins were extracted from
slices hippocampus by homogenizing frozen tissues in lysis buﬀer
(100 mM Tris/HCl, pH 7.0, 1 M NaCl, 4 mM EDTA.Na2, 2%
Triton X-100, 0.1% sodium azide) containing Tissue Protease
Inhibitor Cocktail (Sigma–Aldrich, 1:1000, v/v). Hippocampal
homogenates were centrifuged at 14 000 × g for 30 min at
4◦C and soluble samples were used for ELISA. In detail TNF-
alpha concentration was titrated by sandwich ELISA, using the
TNF-alpha Duo-Set kit (R&D, distributed by DBA Italia, Milan,
Italy), essentially according to the manufacturer instructions.
Each hippocampus homogenate was diluted (1:10, 1:30, and 1:60)
in the assay. Data were reported as pg of TNF-alpha per mg of
proteins.
Real-Time PCR Analysis
Total RNA was extracted according to the TRI-Reagent (Sigma–
Aldrich) protocol. The concentration and purity of RNA samples
were determined by UV absorbance spectrophotometry. RNA
integrity was checked on 1.2 % agarose gel electrophoresis.
First-strand cDNA was synthesized from each total RNA (1 μg)
using the QuantiTect reverse transcription kit (Qiagen). The
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Real Time PCR reactions were carried out in quadruplicate in
an Applied Biosystems 7500 Real Time System by using the
Power SYBR Green Master Mix PCR (Applied Biosystems).
Each SYBR Green reaction (20 μl total volume) contained
2 μl of 1:1 diluted cDNA as template. For internal standard
control, the expression of β-actin gene was quantiﬁed. Primer
sequences were designed using Primer Express software
(Applied Biosystems). Hpt primers were designed on the exon
junction 278/279 (forward primer) on template NM012582.2
(forward primer, 5′- TGAGGCAGTGTGTGGGAAGCCC-3′;
reverse primer, 5′- TGTGGCCCCAGTGGTGAGTCC-3′);
β-actin primers were designed on the exon junction 75/76
(forward primer) on template NM031144.2 (forward primer,
5′- ACCCGCCACCAGTTCGCCAT-3′; reverse primer, 5′-
CGGCCCACGATGGAGGGGAA-3′). Amplicons were 128–
136 bp long. The PCR was performed under the following
conditions: holding stage of 95◦C per 10′; cycling tage (45
cycles): 95◦C × 10 s – 60◦C × 10 s – 72◦C × 10 s; melting stage:
95◦C × 5 s – 65◦C × 1 m – 95◦C × 30 s – 40◦C × 30 s.
PCR ampliﬁcation eﬃciencies were determined and CT
relative quantiﬁcation was done using β-actin gene expression as
internal control to normalize the results.
Electrophoresis and Western Blotting of
Hippocampal Homogenates
Proteins were extracted from hippocampus by homogenizing
frozen tissues (−80◦C) in ten volumes (w/v) of cold RIPA buﬀer
(150 mM NaCl, 50 mM Tris-HCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, pH 8) containing Tissue Protease
Inhibitor Cocktail (Sigma–Aldrich, 1:1000, v/v). Homogenates
were then centrifuged (14,000 g, 45 min, 4◦C) and protein
concentration of supernatants was measured according to a
published procedure (Bradford, 1976).
Aliquots (50 μg) of each homogenate were fractionated by
electrophoresis in denaturing and reducing condition on 12.5%
polyacrylamide gel, as previously reported (Spagnuolo et al.,
2014a). After electrophoresis, proteins were transferred onto
PVDF membrane (1 h, under electric ﬁeld), the membrane
was rinsed in T-TBS and then blocked with T-TBS containing
5% non-fat milk (overnight, 4◦C). The membrane was then
incubated (1 h, 37◦C) with rabbit anti-rat Hpt (1: 500 dilution
in T-TBS containing 0.25% non-fat milk) followed by GAR-
HRP IgG (1: 500 dilution; 1 h, 37◦C). The immunocomplexes
were detected by the ECL detection system, using luminol as
substrate, according to the manufacturer protocol. Quantitative
densitometry of Hpt was then carried out by analyzing
the digital images of membranes by the Gel-Pro Analyzer
software (Media Cybernetics, Silver Spring, MA, USA).
Band intensities were calculated as integrated optical density
(IOD).
After Hpt detection, the membrane was extensively washed
with T-TBS and then submerged in stripping buﬀer (100 mM
β-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl, pH 6.7; 45 min,
50◦C) for reprobing with anti-β-actin. After washing with T-TBS,
the membrane was incubated (1 h, 37◦C) with mouse anti-β-actin
IgG (1:2,000 dilution), followed by GAM-HRP IgG (1:10,000
dilution; 1 h, 37◦C). The immunocomplexes were detected by the
ECL detection system, and densitometric analysis of the signal
was carried out as above. Hpt concentration was then quantiﬁed
after normalization with β-actin, and results were expressed as
arbitrary units.
Analysis of Hb Concentration in Rat
Hippocampus
Haemoglobin concentration in individual samples was measured
by ELISA. Samples were diluted (1:100, 1:400, 1:600, and 1:1000)
with coating buﬀer, and then incubated in the wells of a
microtiter plate (overnight, 4◦C). After four washes by T-TBS
and four washes by high salt TBS, the wells were blocked as
above described (1 h, 37◦C). After washing, the wells were
incubated (1 h, 37◦C) with 60 μl of rabbit anti-human Hb IgG
(1: 500 dilution in T-TBS containing 0.25% BSA) followed by
60 μl of GAR-HRP IgG (1:5000 dilution). Peroxidase-catalyzed
color development from o-phenylenediamine was measured at
492 nm. The calibration curve was obtained by assaying the
immunoreactivity of 1, 0.5, 0.25, 0.1, and 0.05 ng of commercial
Hb standard. Data were reported as μg of Hb per mg of
proteins.
Titration of Nitro-Tyrosine (N-Tyr) in Rat
Hippocampus
N-Tyr in individual samples was quantiﬁed by ELISA. Samples
were diluted (1:100, 1:250, 1:500, and 1:1000) with coating buﬀer,
and aliquots (50 μl) were then incubated in the wells of a
microtiter plate (overnight, 4◦C). After four washes by T-TBS
and four washes by high salt TBS the wells were blocked with
TBS containing 0.5% BSA (1 h, 37◦C). After washing, the wells
were incubated (1 h, 37◦C) with 50 μl of rabbit anti-N-Tyr (1:
1000 dilution in T-TBS containing 0.25% BSA) followed by 60 μl
of GAR-HRP IgG (1:5000 dilution). Peroxidase-catalyzed color
development from o-phenylenediamine was measured at 492 nm.
Data were reported as OD per mg of proteins.
Hpt Secretion by U-87 MG Cell Line
U-87 MG were seeded into six well-plate (400,000 cells/well)
in complete medium and cultured for 20 h. After medium
removal, cells were rinsed with DMEM, and incubated (20 h,
37◦C) in DMEM containing diﬀerent amounts of free cholesterol
(0, 1.5, 3, 6, or 12 μg/ml), or liposome embedded 2-linoleoyl-
1-palmitoyl-sn-glycero-3-phosphocholine (Lipo-LP; 0, 0.1, 0.3,
0.9, or 3 μM), or liposome-embedded PC (Lipo-PC; 0, 0.3, 0.9,
1.6, or 3 μM). At the end of incubation, media samples were
collected, supplemented with Tissue Protease Inhibitor Cocktail
(Sigma–Aldrich, 1:500, v/v), cleared of any cellular debris by
centrifugation (400 g, 10 min), and ﬁnally immunoprecipitated
with 1 μg of rabbit anti-human Hpt (overnight, 4◦C). Twenty
microliter of protein G Plus/protein A Agarose Suspension were
added to each sample, and a further incubation (2 h, 4◦C) was
carried out.
The cells were extensively washed with DMEM, detached by
treatment (5 min, 37◦C) with 500 μl of trypsin (TrypLE Express,
Gibco), and ﬁnally lysed with 0.3 mL of RIPA buﬀer (150 mM
NaCl, 50 mM Tris-HCl, 0.5% NP-40, 0.5% sodium deoxycholate,
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0.1% SDS, pH 8) containing the protease inhibitor cocktail (1:200,
v/v). The lysates were centrifuged (12000 g, 30min, 4◦C) and then
analyzed for their protein concentration (Bradford, 1976).
Immunoprecipitates were analyzed by 12.5% SDS-PAGE, and
Western blotting for revealing Hpt. In detail, after protein
transfer onto PVDF membrane, the blocking was performed as
above described, and Hpt was revealed by incubation (overnight,
4◦C) with mouse anti-human Hpt IgG (1: 500 dilution), followed
by GAM-HRP IgG (1: 8000 dilution; 1 h, 37◦C) and ECL
staining. Quantitative densitometry of the bands was carried
out by analyzing digital images of X-ray ﬁlms exposed to
immunostained membranes. In particular, the images were
analyzed by the Gel-Pro Analyzer software (Media Cybernetics,
Silver Spring, MA, USA), and the intensities of the bands
were recorded as peaks on densitograms. The peak areas were
measured and expressed as IOD, namely IOD. Band intensities
(IOD) per mg of cell protein were then calculated.
Liposomes containing PC or LP were prepared by the cholate
dialysis procedure as previously reported (Chen and Albers,
1982).
Cell Viability Assay
In order to evaluate the eﬀect of cholesterol, Lipo-LP, or Lipo-
PC on survival of U-87 MG, cells were seeded into 96-well plate
(8,000 cells per well), as above described, and cultured for 20 h
in complete medium. After medium removal, cells were rinsed
with DMEM, and incubated (20 h, 37◦C) in DMEM containing
diﬀerent amounts of free cholesterol (0, 1.5, 3, 6, 12, 24, or
40 μg/ml), or Lipo-LP (; 0, 0.1, 0.3, 0.9, 3, 6, or 12 μM), Lipo-
PC (0, 0.3, 0.9, 1.6, 3, 6, or 12 μM). The medium was then
removed and cell survival was evaluated byMTT reduction assay.
In detail, 100 μl of MTT (0.5 mg/ml in DMEM without Phenol
red) were added to each well, and the incubation was carried out
for 3 h at 37◦C. One hundred microliters of a solution containing
0.1 M HCl in isopropanol were then added to each well, and,
after 30 min, the absorbance at 595 nm was measured with a Bio-
Rad 3350 microplate reader. The data were expressed as viability
percentage, assuming the absorbance value from untreated cells
as 100%.
Statistical Analysis
In all experiments samples were processed in triplicate, and data
were expressed as mean value ± SEM. The program “GraphPad
Prism 5.01” (GraphPad Software, San Diego, CA, USA) was used
to perform regression analysis, Student’s t-test, for comparing two
groups of data, and one-way ANOVA, followed by Tukey’s test,
for multiple group comparisons. P < 0.05 was set as indicating
signiﬁcance.
RESULTS
General Features of High Fat Diet Fed
Rats
As shown in Table 2, animals fed HFD showed a signiﬁcantly
higher body weight compared to control groups, both after 12
(574.0 ± 16.6 g vs. 640.0 ± 22.2 g, p = 0.045) and 24 weeks
(614.3 ± 13.1 g vs. 714.5 ± 20.1 g, p = 0.045). In addition,
weight gain was higher in the HFD group compared to CD group
both after 12 (296.2 ± 21.6 g vs. 231.5 ± 15.8 g; 86 ± 6.2%
vs. 66.1 ± 4.7%; p = 0.04) and 24 weeks (372 ± 20.6 g vs.
269 ± 11.8 g; 108.6 ± 6.6% vs. 77.7 ± 3.15%; p = 0.0004). The
diet-dependent increase in body weight was also aﬀected by the
duration of diet administration (p < 0.05), in the HFD group
(p = 0.03), while was not aﬀected by the length of treatment
in the control group (Table 2). Further, the analysis of body
composition after 12 weeks of treatment revealed that lipid
content was higher in HFD than in CD rats (33.06 ± 1.13%
vs. 15.18 ± 0.38%; p < 0.001). Water and protein contents
were signiﬁcantly lower in HFD rats compared to CD rats
(water, 48.46 ± 1.08% vs. 63.22 ± 0.44%, p < 0.001; protein,
12.82 ± 0.40% vs. 14.40 ± 0.46%, p = 0.03).
Cholesterol serum level was signiﬁcantly higher in rats
receiving HFD for 12 or 24 weeks compared to those receiving
the CD for the same period (p < 0.001), but it was not aﬀected
by the duration of treatment. Serum and hepatic triglycerides
levels were higher in HFD fed rats than in CD rats, in both
groups (p < 0.001). In addition, a time-dependent eﬀect was
observed, as triglycerides concentration was more elevated in rats
fed for 24 weeks compared to those fed for 12 weeks, in both CD
and HFD groups (p < 0.001). A similar result was obtained by
evaluating serum ALT (Table 2) as marker of hepatic function.
Indeed ALT was higher (1.18 ± 0.01-fold, p < 0.001) in rats
receiving HFD for 12 or 24 weeks respect to those receiving CD
for the same period, as well as in 24 weeks fed rats compared to
12 weeks in both CD and HFD groups.
TABLE 2 | Body weight and serum parameters.
Control High fat diet
12 weeks 24 weeks 12 weeks 24 weeks
Body weight (g) 574.0 ± 16.6a 614.3 ± 13.1a 640.0 ± 22.2b 714.5 ± 20.1c
Weight gain % 66.11 ± 4.70a 78.00 ± 2.90a 86.12 ± 6.20b 108.61 ± 6.61c
Cholesterol (mg/dL) 65.17 ± 0.75a 66.00 ± 1.82a 75.00 ± 0.92b 77.40 ± 0.68b
Triglycerides (mg/dL) 103.7 ± 3.43a 118.4 ± 4.08b 128.5 ± 4.90b 139.6 ± 2.06c
ALT (U/I) 66.67 ± 2.01a 72.80 ± 1.36b 79.83 ± 1.30c 91.00 ± 1.78d
Hepatic Triglycerides (mg/g) 5.10 ± 0.10a 6.40 ± 0.20b 10.20 ± 0.30c 13.70 ± 0.20d
ALT, alanine amino transferase. Data are the means ± SE. Data with different superscripted letters are significantly different (p < 0.05).
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Serum Level of Markers of Inflammation
In order to study the eﬀect of HFD diet on systemic markers of
inﬂammation, serum TNF-alpha and Hpt levels were measured
(Figure 1). TNF-alpha concentration was signiﬁcantly higher
(p < 0.05) in rats receiving HFD for 12 or 24 weeks respect
to those receiving CD for the same period. TNF-alpha was
found not to be time-dependent in CD group (CD 12,
0.122 ± 0.014 ng/mL; CD 24, 0.125 ± 0.006 ng/mL) or in HFD
group (0.161 ± 0.02 ng/mL; HFD 24, 0.158 ± 0.013 ng/mL).
SerumHpt level did not diﬀer between control and treated rats
both at 12 and 24 weeks. A time-dependent trend of increase in
Hpt concentration was observed (CD 12, 0.353 ± 0.082 mg/mL;
CD 24, 0. 0.447 ± 0.031 mg/mL; HFD 12, 0.441 ± 0.088 mg/mL,
HFD 24, 0.503± 0.038 mg/mL), although this was not signiﬁcant
in all groups.
It was previously demonstrated that in obese mice, which
show increased serum Hpt after 12 weeks of treatment, Hpt
expression was increased in WAT, but not in liver, suggesting
that obesity induces a speciﬁc WAT Hpt upregulation (Lisi
et al., 2011). In our experimental conditions, HFD fed rats
showed a Hpt concentration 1.2-fold higher than CD rats, but
this diﬀerence was not signiﬁcant (0.441 ± 0.088 mg/mL vs.
0.353 ± 0.082 mg/mL). Conversely, serum Hpt, after 4 weeks
of diet administration, was signiﬁcantly higher in HFD than
in CD rats (0.295 ± 0.022 mg/mL vs. 0.185 ± 0.019 mg/mL,
p = 0.03; data not shown). This led us to suppose that
in our experimental model (rat fed a diet rich in lard) a
signiﬁcant increase of Hpt just occurs in the initial phase of
treatment.
FIGURE 1 | Serum level of inflammation markers. TNF-alpha (open bar)
and Haptoglobin (Hpt; black bar) concentrations were measured by ELISA in
serum of rats fed high-fat diet (HFD) or standard diet (control diet, CD) for 12
(CD 12, N = 8; HFD 12, N = 6) or 24 (CD 24, N = 7; HFD 24, N = 7) weeks.
Each sample was analyzed in triplicate. Data were expressed as ng/ml
(TNF-alpha) or mg/ml (Hpt), and reported as mean ± SEM. Significant
differences between groups are indicated (∗, values significantly different from
control by Student’s t-test, p < 0.05).
TNF-Alpha Concentration in Rat
Hippocampus
TNF-alpha was titrated by sandwich ELISA, and signiﬁcant
diet-related changes of its level in hippocampus were observed
(Figure 2). In particular, TNF-alpha concentration was about
1.5 (p < 0.01) or twofold (p < 0.001) higher in rats receiving
HFD for 12 or 24 weeks compared to those receiving the CD
for the same period. Further, we found that the duration of HFD
administration did not aﬀect hippocampal concentration of this
cytokine. These results demonstrate that HFD, containing mainly
lard as source of fat, induces brain inﬂammation, in agreement
with previously published data (Thirumangalakudi et al., 2008;
Wang et al., 2012), and that the eﬀect was detectable within
12 weeks.
Analysis of Hpt in Rat Hippocampus
We previously reported that aging is associated with an increase
of Hpt concentration and mRNA level in rat hippocampus
(Spagnuolo et al., 2014a). As no data are available on the eﬀect
of HFD on brain expression of Hpt, we evaluated Hpt mRNA
and protein levels in hippocampus of rats fed a HFD for 12 or
24 weeks. Hpt concentration, as detected by Western blotting,
was signiﬁcantly aﬀected by the diet. As a matter of fact, Hpt
level was lower (p < 0.001, Figure 3A) in hippocampus of HFD
rats than in control animals, both in the group receiving the
diet for 12 weeks (HFD 12, about 1.9-fold) and in 24 weeks
group (HFD 24; about 3.5-fold). Further, in control animals,
we found that Hpt concentration was about twofold higher
(p < 0.001) in hippocampus of CD 24 compared with CD
12 rats, in line with our previously published data (Spagnuolo
FIGURE 2 | TNF-alpha concentration in rat hippocampus. TNF-alpha
was titrated by sandwich ELISA in hippocampus of rats fed high-fat diet (HFD,
black bar) or standard diet (control diet, CD, open bar) for 12 or 24 weeks.
Each sample was analyzed in triplicate. Data were expressed as pg per mg of
protein, and are reported as mean ± SEM. Significant differences between
groups are indicated (∗∗values significantly different from control by Student’s
t-test, p < 0.01; ∗∗∗values significantly different from control by Student’s
t-test, p < 0.001).
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FIGURE 3 | Hpt expression in rat hippocampus. Haptoglobin protein (A)
and mRNA (B) levels in hippocampus of rats fed high-fat (HFD) or standard
diet (control diet, CD) for 12 or 24 weeks. (A) On the left, representative
Western blots are shown. Samples were analyzed by 12.5% SDS-PAGE and
western blotting. Immunocomplexes were detected by rabbit anti-Hpt and
GAR-HRP IgGs. After Hpt detection, the membrane was stripped and
reprobed with anti-β-actin. On the right, quantitative densitometry of Hpt and
β-actin was carried out and band intensities were calculated. Hpt
concentrations are shown relative to β-actin level. Significance of differences is
shown. ∗∗∗values significantly different from control by Student’s t-test,
p < 0.001. (B) mRNA level of Hpt is shown relative to the β-actin mRNA. The
data represent the mean ± SEM.
et al., 2014a), while the duration of HFD had no eﬀect on
Hpt concentration. Conversely, Real Time-PCR revealed no
signiﬁcant diet-related changes of Hpt expression (Figure 3B).
An in silico analysis was performed using the RegRNA2.0
platform (http://regrna2.mbc.nctu.edu.tw/; Chang et al., 2013),
and no AU-rich regions (ARE) in Hpt mRNA were found, thus
suggesting that the observed diet-dependent decrease of protein
concentration might be due to diet eﬀects on Hpt synthesis
and/or on Hpt stability.
Analysis of Hb and N-Tyr Concentration
in Hippocampus
Free Hb is highly toxic (Alayash, 2004), due to the presence of
heme, that disrupts the lipid bilayers, and to the well known
ability of iron to cause protein oxidation in vivo and in vitro (Qu
et al., 2005). Hb was also reported to induce reactive oxygen and
nitrogen species (superoxide radical and nitric oxide) production
(Katsu et al., 2010; Yang et al., 2013). We therefore investigated
whether HFD aﬀects brain Hb concentration as well. Hb level,
as assessed by ELISA, was signiﬁcantly higher (about 1.8-fold,
p < 0.01) in hippocampus of rats receiving the HFD for 12 or
24 weeks than in rats receiving the CD, while it was not aﬀected
by the duration of diet (Figure 4). Although a trend toward
a time-dependent decrease in concentration was observed, the
duration of treatment did not signiﬁcantly aﬀect hippocampal
level of Hb neither in CD (CD 12, 0.489 ± 0.056 μg/mg protein;
CD 24, 0.427 ± 0.033 μg/mg protein) nor in HFD group (HFD
12, 0.806 ± 0.114 μg/mg protein, HFD 24, 0.763 ± 0.072 μg/mg
protein).
As known, Hpt binds with high aﬃnity free Hb, thus
preventing Hb-related oxidative damage and also limiting the
release of heme (Quaye, 2008). The ﬁnding of higher level
of Hb in hippocampus of HFD fed rats, with lower Hpt
concentration, led us to hypothesize that the diet-dependent
decrease of Hpt, which is known to act as antioxidant, might
be associated with a higher extent of oxidative stress. In
order to verify this hypothesis, we analyzed N-Tyr level in
hippocampus of CD and HFD fed rats as marker of oxidative
stress. It was previously reported that HFD administration to
rats with a maternal history of HFD consumption prior to
pregnancy is associated with the increase of N-Tyr level in
cerebral cortex (White et al., 2009). We found that N-Tyr level
was more elevated in hippocampus of HFD than in CD rats
in both 12 weeks (35.04 ± 5.289 vs. 22.95 ± 2.318 OD/mg
protein, p = 0.04) and 24 weeks groups (41.10 ± 7.163 vs.
19.62 ± 2.355 OD/mg protein, p = 0.01). These results support
the hypothesis that HFD might induce protein oxidative damage
in brain. Further, a positive correlation between Hb and N-Tyr
concentration was found in each group (Figure 5; CD 12,
r = 0.815, p = 0.014; HFD 12, r = 0.837, p = 0.038; CD
24, r = 0.855, p = 0.014; HFD 24, r = 0.786, p = 0.036),
in line with recent ﬁndings demonstrating that Hb induces
peroxynitrite formation in vivo (Ding et al., 2014, 2015). These
data suggest that HFD is accompanied by an increase of Hb
FIGURE 4 | Haemoglobin (Hb) concentration in rat hippocampus.
Hb level was measured by ELISA in hippocampus of rats fed HFD or control
diet (CD) for 12 or 24 weeks. Each sample was analyzed in triplicate. Data
were expressed as μg per mg of protein, and are reported as mean ± SEM.
Significant differences between groups are indicated (∗values significantly
different from control by Student’s t-test, p < 0.05; ∗∗∗values significantly
different from control by Student’s t-test, p < 0.001).
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FIGURE 5 | Correlation between N-Tyr and Hb concentration in rat
hippocampus. (A) Hb and N-Tyr concentrations were measured by ELISA in
hippocampus of rats fed high-fat (HFD, full squares) or control (CD, open
squares) diet for 12 weeks. The statistical program Graph Pad Prism 5.01
performed the regression analysis and the calculation of P (CD, r = 0.815,
p = 0.014; HFD, r = 0.837, p = 0.038). (B) Hb and N-Tyr concentrations
were measured by ELISA in hippocampus of rats fed high-fat (HFD, full
triangles) or control (CD, open triangles) diet for 24 weeks. The statistical
program Graph Pad Prism 5.01 performed the regression analysis and the
calculation of P (CD, r = 0.855, p = 0.014; HFD, r = 0.786, p = 0.036).
level in hippocampus which, in turn, is associated with protein
oxidative modiﬁcation.
Cholesterol and Phospholipids Effect on
Hpt Production by U-87 MG Astrocytes
We previously demonstrated that U-87 MG astrocytes are able
to synthesize and secrete Hpt (Maresca et al., 2015). As HFD
was reported to alter brain lipid metabolism and composition
(Freeman et al., 2014) and our results show an eﬀect on Hpt
brain level, we investigated whether Hpt production by human
astrocytes can be inﬂuenced by lipid treatment. To this aim, we
choose for the in vitro treatment, cholesterol, LP, and PC that in
terms of fatty acids composition are similar to lard, the major
component of HFD used for rats treatment. Preliminarily, the
eﬀect of these compounds on U-87 viability was evaluated by
MTT assay, in order to choose lipid concentration not aﬀecting
cell survival (data not shown).
U-87 were incubated (20 h, 37◦C) in DMEM containing
diﬀerent amounts of Lipo-PC (0, 0.3, 0.9, 1.6, or 3 μM), or
free cholesterol (0, 1.5, 3, 6, or 12 μg/ml), or Lipo-LP (0;
0.1, 0.3, 0.9, or 3 μM). After each treatment, cell culture
supernatants were immunoprecipitated by monoclonal anti-
human Hpt and then immunostained with polyclonal anti-
Hpt. A signiﬁcant dose-dependent decrease of Hpt level in
supernatants from astrocyte treated with cholesterol or Lipo-
LP was found. In particular, the amount of Hpt was reduced
of about threefold by treatment with 1.5 μg/ml cholesterol
(p < 0.001) and of about fourfold by treatment with 3 μg/ml
cholesterol (p < 0.001). As shown in Figure 6, a sevenfold
decrease (p < 0.001) of Hpt amount was induced by cell
incubation with 12 μg/ml cholesterol. Lipo-LP treatment also
impaired Hpt secretion, inducing a 2.5-fold decrease of Hpt level
(p < 0.001) at the higher concentration used. Conversely, Lipo-
PC treatment did not aﬀect Hpt secretion. These results suggest
that cholesterol and fatty acids, such as palmitic and linoleic acid,
can interfere with Hpt release by U-87 MG in the extracellular
compartment.
DISCUSSION
The neurodegeneration and the inﬂammation/obesity are
becoming an inseparable binomial association. Nutrition-related
eﬀects on brain function have been extensively investigated in
the last decade, and it was strongly suggested that obesity and
increased consumption of HFD increase risk for development
of dementia (Luchsinger et al., 2002; Hebert et al., 2003;
Solfrizzi et al., 2003; Craft, 2009), although it remains to clarify
the molecular mechanisms responsible for these phenomena.
Oxidative stress and inﬂammation were suggested to play a
central role in causing HFD-induced damage to the brain
(Freeman et al., 2014).
To unveil the biochemical and molecular mechanisms
underlying the brain consequences of dietary fats, it could be
useful to identify factors that signiﬁcantly change in the brain
following HFD administration. Hpt represents an interesting tool
to further explore the relationship between diet and inﬂammation
in brain. Beneﬁcial eﬀects of this protein were already shown,
since it plays a critical role in brain, defending neurons
from Hb-induced damage after intracerebral hemorrhage (Zhao
et al., 2009). Also, Hpt prevents ApoE and ApoA-I oxidation
(Salvatore et al., 2007, 2009), and modulates ApoE-mediated
cholesterol traﬃcking in neuroblastoma cell lines (Spagnuolo
et al., 2014a).
Here we demonstrate, for the ﬁrst time, that Hpt protein level
is signiﬁcantly reduced in hippocampus of rats fed for a long term
(until 12 or 24 weeks) a high fat diet. In contrast, Hpt mRNA
did not change in response to dietary intervention. As no ARE
regions, which are known to aﬀect mRNA stability, were found
in rat Hpt mRNA, diﬀerences between Real time and Western
blotting results might be due to diet eﬀects on Hpt synthesis
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FIGURE 6 | Haptoglobin secretion by U-87 MG. U-87 MG were incubated into six well-plate (20 h; 400,000 cells/well) in DMEM containing different amounts of
liposome-embedded PC (Lipo-PC; 0, 0.3, 0.9, 1.6, or 3 μM), or free cholesterol (0, 1.5, 3, 6, or 12 μg/ml), or liposome embedded LP (Lipo-LP; 0, 0.1, 0.3, 0.9, or
3 μM). At the end of incubation, media samples were collected, immunoprecipitated with rabbit anti-human Hpt, and finally analyzed by electrophoresis on 12.5%
polyacrylamide gel, under denaturing and reducing conditions, and Western Blotting. Representative Western blotting are shown (left). Hpt in the supernatants
(indicated with an arrow) was detected by mouse anti-human Hpt IgG and GAM-HRP IgG. Standard, commercial Hpt 1-1 (50 ng). Quantitative densitometry was
carried out by the Gel-Pro Analyzer software (right). The intensities of the bands were measured and expressed as IOD, namely Integrated Optical Density. Band
intensities (IOD) per mg of cell protein were then calculated. Significance of difference from control (cells cultured in the absence of treatment; open bar) is shown.
∗∗∗p < 0.001.
and/or on Hpt stability. This discrepancy between mRNA and
protein levels is observed for many proteins in mammalian cells,
and may indicate that the modulation of HFD in the brain might
be exerted mainly at the protein level (Vogel and Marcotte,
2012).
The concentration of TNF-alpha, a cytokine known to exert
pleiotropic functions in central nervous system pathogenesis
(McCoy and Tansey, 2008) was higher in hippocampus of high-
fat fed rats, thus indicating a diet-induced inﬂammation, which
might contribute to oxidative brain injury. Indeed it was reported
that inﬂammation is associated with the release of reactive
oxygen and nitrogen species (Urrutia et al., 2014), and with
the activation of inducible nitric oxide synthase (iNOS) gene
in astrocytes and microglia (Possel et al., 2000; Hewett and
Hewett, 2012). In this study we detected a higher amount of
Hb in hippocampus of HFD fed rats that exhibit lower Hpt
content, compared to CD fed rats. It is worth mentioning that a
quote of brain Hb can derive from the transient extravasation of
erythrocytes or from neutrophils from the peripheral circulation
(Chuang et al., 2012). As accumulating evidence suggest that
HFD can alter vascular components of the brain, leading to BBB
disruption and dysfunction of brain endothelial cells (Freeman
et al., 2014), changes to vascularization/BBB integrity might
be responsible for the observed increase of cerebral Hb. On
the other hand, Hb was previously detected in neurons from
rat brains (Richter et al., 2009; Schelshorn et al., 2009), and
it was proposed it is responsible for O2 homeostasis in this
area (Biagioli et al., 2009). Expression of Hb is enhanced
by hypoxia (Schelshorn et al., 2009), and obesity-induced
cerebral hypoperfusion, derived from endothelial dysfunction,
was reported (Toda et al., 2014). Therefore, it cannot be excluded
that the up-regulation of Hb that we observed might be a
feedback response to hypoxia. Exogenous Hb released from
red blood cells after traumatic brain injury or intracerebral
hemorrhage is highly neurotoxic (Xi et al., 2006), and increased
expression of Hpt was reported to protect neurons against
hypoxic-ischemic injury (Zhao et al., 2009). As Hpt binds with
extremely high aﬃnity Hb, the reduction of brain Hpt might
be associated with an increased brain damage. By forming Hpt-
Hb complexes, Hpt stabilizes and shields heme iron within
the hydrophobic pocket of Hb, thereby preventing its pro-
oxidative properties and cytotoxicity (Yang et al., 2003; Quaye,
2008). Indeed, excessive Hb and iron overload induce oxidative
injury and signiﬁcantly contribute to brain damage (Xi et al.,
2006). Further, it was previously reported that high fat diet
induces oxidative stress and endothelial dysfunction in rats,
essentially by down-regulation of antioxidant enzymes, such as
superoxide dismutase, catalase, glutathione peroxidase, and heme
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oxygenase-2 (HO-2; Roberts et al., 2006). So it was expected
a higher extent of oxidative damage in brain of HFD fed rats.
We measured N-Tyr in rat hippocampus as marker of protein
oxidation induced by peroxynitrite, which, in turn, is produced
by reaction of superoxide and nitric oxide. Tyrosine nitration
was reported to be involved in the pathogenesis of numerous
neurodegenerative disorders (Sacksteder et al., 2006; Lee et al.,
2009; Yeo et al., 2015), and increased protein tyrosine nitration
in aorta, kidney, heart and liver of rats, in response to HFD
administration, was previously described (Roberts et al., 2000;
Ghosh et al., 2006; Bautista et al., 2014). As a matter of fact
we found increased levels of N-Tyr in hippocampus of HFD
fed rats, likely due to the higher level of Hb, which is known
to induce superoxide radical, nitric oxide, and peroxynitrite
production (Katsu et al., 2010; Yang et al., 2013; Ding et al.,
2014, 2015). This pro-oxidative eﬀect of Hb could be ampliﬁed
by the reduction of Hpt, the major Hb-scavenger. Based on these
data, we hypothesize that in the obese rat the metabolic activity
of oligodendrocytes and astrocytes, which are the main source
of Hpt in the brain (Zhao et al., 2009; Maresca et al., 2015), is
altered by the HFD, and/or these cells are aﬀected by oxidative
stress and become less abundant in the brain population. In the
attempt of unraveling this mechanism, we investigated the eﬀect
of cholesterol, LP or PC on Hpt synthesis by astrocytes in vitro.
Thesemolecules were chosen tomimic, also in terms of fatty acids
composition, the eﬀect of lard, which is the major component
of the HFD used in this study. Our data demonstrate that Hpt
secretion is signiﬁcantly impaired by cholesterol or LP treatment,
strongly suggesting that the release of this glycoprotein can be
aﬀected by the alteration of lipid composition of the brain.
CONCLUSION
We report evidence that the administration of HFD is associated
with the decrease of Hpt, and with the increase of Hb level and
protein oxidative modiﬁcation in hippocampus. These ﬁndings
led us to hypothesize that Hpt decrease might enhance the
oxidative stress induced by free Hb. In addition, as Hb was shown
to promote the release of inﬂammatory cytokines by microglia
(Wang et al., 2014), we speculate that Hpt, by binding Hb,
might prevent this pro-inﬂammatory function. Therefore, the
concomitant reduction of Hpt and increase of Hb level in brain
ofHFD ratsmight contribute to inﬂammatory cerebral injury. On
the other hand, since Hpt actively participates in critical processes
such as immune cells recruitment, tissue repair and regeneration
(Quaye, 2008), it cannot be excluded that its reduction in brain
may have important implications in diet enhanced brain damage.
It remains to assess whether other cerebroprotective factors,
such as HO-2, the O2 sensor in brain, that contributes to
maintain neuronal physiological functions and to regulate the
vascular tone of cerebral blood vessels (Parfenova and Leﬄer,
2008), are aﬀected by diet administration. Nevertheless, our data,
identifying Hpt as a molecule modulated in the brain by dietary
fats, may represent one of the ﬁrst steps in the comprehension
of the molecular mechanism underlying the diet-related eﬀects in
the nervous system.
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